| Serial Number | 98140452 |
| Word Mark | VOYAGER THERAPEUTICS |
| Filing Date | Friday, August 18, 2023 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Monday, September 23, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the word "VOYAGER" above the word "THERAPEUTICS" with a half circle between the "VOY" and "AGER" portions of the mark. |
| Goods and Services | Biological preparations for gene therapy; adeno-associated virus (AAV) gene therapy preparations and pharmaceuticals; Biological preparations for treatment of neurological diseases and disorders; antibody and gene therapy preparations for treatment of disease, namely, neurological diseases; medical preparations and pharmaceuticals for treatment of neurological diseases via antibody, gene replacement, gene knockdown, or vectorized antibodies; antibody and gene therapy preparations for neurological diseases; nucleic acids encoding polypeptides for gene therapy; Drug delivery agents comprising compounds that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics; Drug delivery agents comprising capsids viral platforms, and non-viral platforms, that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics; pharmaceutical for the treatment of neurodegenerative diseases and diseases of the central nervous system, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), Parkinson's disease, Friedreich's Ataxia, Huntington's disease, and prion disease |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Collaboration services in the field of platform technologies for delivery of therapies and pharmaceuticals, namely, licensing of intellectual property |
| Goods and Services | Medical services provided for clinical trials; providing patient care for clinical trials; providing medical information in the field of gene therapy; providing a website featuring medical information; medical treatment of neurological diseases, neurodegenerative diseases, and diseases of the central nervous system, including Alzheimer's disease, amyotrophic lateral sclerosis (ALS), Parkinson's disease, Friedreich's Ataxia, and Huntington's disease, and prion disease |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Biotechnology research services; research and development of platform technologies for delivery of therapies; research and development of platform technologies for delivery of gene therapies, antibody therapies and pharmaceuticals; research and development regarding the use of RNA-based functional screening platforms to discover, research and develop novel capsids for genetic delivery of therapies and pharmaceuticals; Pharmaceutical research and development in the field of gene therapy and antibody therapy; Pharmaceutical research and development for the treatment of neurological diseases and disorders; scientific research in the field of gene therapy and antibody therapy; pharmaceutical research services; research and development of pharmaceutical preparations for non-viral and gene therapy; research and development of pharmaceutical preparations for neurological diseases; biotechnology research services; research and development in the pharmaceutical and biotechnology fields; research and development regarding the delivery of therapies across the blood-brain barrier; research and development regarding the non-viral and viral vectors for the delivery of therapeutic agents; research and development regarding the identification and targeting of specific cells and tissues for gene therapy; providing scientific research information in the field of clinical trials; hosting a website featuring medical research information |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 18, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 18, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 18, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 18, 2023 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Voyager Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Lexington, MA 02421 |
| Event Date | Event Description |
| Tuesday, September 19, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, August 22, 2023 | NEW APPLICATION ENTERED |
| Monday, September 18, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 23, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 17, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, April 23, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, April 23, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, July 22, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, July 22, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, July 22, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, July 23, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, July 23, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, September 19, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, September 19, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, September 19, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, September 20, 2024 | ASSIGNED TO LIE |
| Monday, September 23, 2024 | LETTER OF SUSPENSION E-MAILED |
| Friday, September 20, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Monday, September 23, 2024 | SUSPENSION LETTER WRITTEN |
| Monday, September 23, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |